AA

Aneri Aniket Chavan

Active Director Director DIN 07531975
DIN 07531975 First appointment Jun 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value •••• Premium profile

About Aneri Aniket Chavan

Data last updated:

Aneri Aniket Chavan is a Director at Cardkem Pharma Private Limited (since 2016). The company operates in Pharma. Cardkem Pharma Private Limited reported revenue of ₹11.60 Cr (FY 2024).

DIN 07531975
Primary Designation Director
Industry Pharma
First Appointment 01 Jun 2016
Oldest Company Age 36 yrs
Largest company Cardkem Pharma Private Limited · ₹11.60 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cardkem Pharma Private Limited U24230GJ1990PTC013672
Director01 Jun 20161990₹11.60 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Cardkem Pharma Private Limited
Premium access

Shareholding and investment profile for Aneri Aniket Chavan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aneri Aniket Chavan

Aneri Aniket Chavan currently holds 1 directorship: Cardkem Pharma Private Limited (Director, since 01 Jun 2016, revenue ₹11.60 Cr (FY 2024)).

Aneri Aniket Chavan was first appointed on 01 Jun 2016 as Director at Cardkem Pharma Private Limited.

The current boards of Aneri Aniket Chavan's companies include Abha Amit Chavan (Cardkem Pharma Private Limited), Amit Ashok Chavan (Cardkem Pharma Private Limited), Aniket Ashok Chavan (Cardkem Pharma Private Limited), Ashok Jaywantrao Chavan (Cardkem Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available